• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biopersistence and brain translocation of aluminum adjuvants of vaccines

Emily

Editor, Senior Moderator
Biopersistence and brain translocation of aluminum adjuvants of vaccines
Romain Kroum Gherardi *, Housam Eidi , Guillemette Cr?peaux, Fran?ois Jerome Authier and
Josette Cadusseau
Facult? de M?decine and Facult? des Sciences et Technologie, INSERM U955 Team 10, Universit? Paris Est-Cr?teil, Cr?teil, France

Aluminum oxyhydroxide (alum) is a crystalline compound widely used as an immunological
adjuvant of vaccines. Concerns linked to the use of alum particles emerged following
recognition of their causative role in the so-called macrophagic myofasciitis (MMF)
lesion detected in patients with myalgic encephalomyelitis/chronic fatigue/syndrome.MMF
revealed an unexpectedly long-lasting biopersistence of alum within immune cells in presumably
susceptible individuals, stressing the previous fundamental misconception of its
biodisposition.We previously showed that poorly biodegradable aluminum-coated particles
injected into muscle are promptly phagocytosed in muscle and the draining lymph nodes,
and can disseminate within phagocytic cells throughout the body and slowly accumulate in
brain.This strongly suggests that long-term adjuvant biopersistence within phagocytic cells
is a prerequisite for slow brain translocation and delayed neurotoxicity. The understanding
of basic mechanisms of particle biopersistence and brain translocation represents a major
health challenge, since it could help to define susceptibility factors to develop chronic
neurotoxic damage. Biopersistence of alum may be linked to its lysosome-destabilizing
effect, which is likely due to direct crystal-induced rupture of phagolysosomal membranes.
Macrophages that continuously perceive foreign particles in their cytosol will likely reiterate,
with variable interindividual efficiency, a dedicated form of autophagy (xenophagy)
until they dispose of alien materials. Successful compartmentalization of particles within
double membrane autophagosomes and subsequent fusion with repaired and re-acidified
lysosomes will expose alum to lysosomal acidic pH, the sole factor that can solubilize alum
particles. Brain translocation of alum particles is linked to a Trojan horse mechanism previously
described for infectious particles (HIV, HCV), that obeys to CCL2, signaling the major
inflammatory monocyte chemoattractant.
Keywords: alum, vaccine adjuvants, macrophagic myofasciitis, neurotoxicity, genetics, monocytes, CCL2, MCP1
 
Back
Top Bottom